Literature DB >> 33500503

Overcoming limitations in the availability of swabs systems used for SARS-CoV-2 laboratory diagnostics.

Rosa Bellmann-Weiler1, Miriam Ladstätter2, Falko Schüllner2, Manfred Nairz3, Martina Zimmermann1, Anna-Maria Koller1, Silvia Blunder1, Helene Naschberger1, Werner Klotz1, Manfred Herold1, Sylvia Kerndler2, Martina Jeske2, David Haschka1, Verena Petzer4, Andrea Schroll1, Thomas Sonnweber1, Ivan Tancevski1, Gernot Fritsche1, Mariana E G de Araujo5, Taras Stasyk5, Lukas A Huber5, Andrea Griesmacher6, Igor Theurl1, Günter Weiss1.   

Abstract

The diagnosis of COVID-19 relies oene">n the direct detectioene">n of n class="Species">SARS-CoV-2 RNA in respiratory specimens by RT-PCR. The pandemic spread of the disease caused an imbalance between demand and supply of materials and reagents needed for diagnostic purposes including swab sets. In a comparative effectiveness study, we conducted serial follow-up swabs in hospitalized laboratory-confirmed COVID-19 patients. We assessed the diagnostic performance of an in-house system developed according to recommendations by the US CDC. In a total of 96 serial swabs, we found significant differences in the accuracy of the different swab systems to generate a positive result in SARS-CoV-2 RT-PCR, ranging from around 50 to 80%. Of note, an in-house swab system was superior to most commercially available sets as reflected by significantly lower Ct values of viral genes. Thus, a simple combination of broadly available materials may enable diagnostic laboratories to bypass global limitations in the supply of swab sets.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33500503      PMCID: PMC7838421          DOI: 10.1038/s41598-021-81782-8

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  50 in total

1.  Interpreting Diagnostic Tests for SARS-CoV-2.

Authors:  Nandini Sethuraman; Sundararaj Stanleyraj Jeremiah; Akihide Ryo
Journal:  JAMA       Date:  2020-06-09       Impact factor: 56.272

2.  Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore.

Authors:  Barnaby Edward Young; Sean Wei Xiang Ong; Shirin Kalimuddin; Jenny G Low; Seow Yen Tan; Jiashen Loh; Oon-Tek Ng; Kalisvar Marimuthu; Li Wei Ang; Tze Minn Mak; Sok Kiang Lau; Danielle E Anderson; Kian Sing Chan; Thean Yen Tan; Tong Yong Ng; Lin Cui; Zubaidah Said; Lalitha Kurupatham; Mark I-Cheng Chen; Monica Chan; Shawn Vasoo; Lin-Fa Wang; Boon Huan Tan; Raymond Tzer Pin Lin; Vernon Jian Ming Lee; Yee-Sin Leo; David Chien Lye
Journal:  JAMA       Date:  2020-04-21       Impact factor: 56.272

3.  Specimen Age Stability for Human Papilloma Virus DNA Testing Using BD SurePath.

Authors:  Melanie J Kubik; Terri Permenter; Jinous Saremian
Journal:  Lab Med       Date:  2015

4.  Season of birth, childhood asthma and allergy in a nationwide cohort-Mediation through lower respiratory infections.

Authors:  Catarina Almqvist; Sara Ekberg; Samuel Rhedin; Fang Fang; Tove Fall; Cecilia Lundholm
Journal:  Clin Exp Allergy       Date:  2019-12-28       Impact factor: 5.018

5.  Optimal specimen collection and transport methods for the detection of avian influenza virus and Newcastle disease virus.

Authors:  Erica Spackman; Janice C Pedersen; Enid T McKinley; Jack Gelb
Journal:  BMC Vet Res       Date:  2013-02-22       Impact factor: 2.741

6.  Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays.

Authors:  Angelica Moran; Kathleen G Beavis; Scott M Matushek; Carol Ciaglia; Nina Francois; Vera Tesic; Nedra Love
Journal:  J Clin Microbiol       Date:  2020-07-23       Impact factor: 5.948

7.  Clinical Features and Outcomes of 105 Hospitalized Patients With COVID-19 in Seattle, Washington.

Authors:  Frederick S Buckner; Denise J McCulloch; Vidya Atluri; Michela Blain; Sarah A McGuffin; Arun K Nalla; Meei-Li Huang; Alex L Greninger; Keith R Jerome; Seth A Cohen; Santiago Neme; Margaret L Green; Helen Y Chu; H Nina Kim
Journal:  Clin Infect Dis       Date:  2020-11-19       Impact factor: 9.079

8.  Negative Nasopharyngeal and Oropharyngeal Swabs Do Not Rule Out COVID-19.

Authors:  Poramed Winichakoon; Romanee Chaiwarith; Chalerm Liwsrisakun; Parichat Salee; Aree Goonna; Atikun Limsukon; Quanhathai Kaewpoowat
Journal:  J Clin Microbiol       Date:  2020-04-23       Impact factor: 5.948

9.  Comparison of Copan ESwab and FLOQSwab for COVID-19 Diagnosis: Working around a Supply Shortage.

Authors:  Christie Vermeiren; Xavier Marchand-Senécal; Elena Sheldrake; David Bulir; Marek Smieja; Sylvia Chong; Jessica D Forbes; Kevin Katz
Journal:  J Clin Microbiol       Date:  2020-05-26       Impact factor: 5.948

10.  Viral kinetics of SARS-CoV-2 in asymptomatic carriers and presymptomatic patients.

Authors:  Seong Eun Kim; Hae Seong Jeong; Yohan Yu; Sung Un Shin; Soosung Kim; Tae Hoon Oh; Uh Jin Kim; Seung-Ji Kang; Hee-Chang Jang; Sook-In Jung; Kyung-Hwa Park
Journal:  Int J Infect Dis       Date:  2020-05-04       Impact factor: 3.623

View more
  6 in total

1.  Characteristics of chest high resolution computed tomography images of COVID-19: A retrospective study of 46 patients.

Authors:  Yibo Lu; Jingru Zhou; Yimei Mo; Shulin Song; Xue Wei; Ke Ding
Journal:  Pak J Med Sci       Date:  2021 May-Jun       Impact factor: 1.088

Review 2.  Diagnostic assay and technology advancement for detecting SARS-CoV-2 infections causing the COVID-19 pandemic.

Authors:  Bidhan C Dhar
Journal:  Anal Bioanal Chem       Date:  2022-02-25       Impact factor: 4.478

3.  Sample-to-answer, extraction-free, real-time RT-LAMP test for SARS-CoV-2 in nasopharyngeal, nasal, and saliva samples: Implications and use for surveillance testing.

Authors:  Kathryn A Kundrod; Mary E Natoli; Megan M Chang; Chelsey A Smith; Sai Paul; Dereq Ogoe; Christopher Goh; Akshaya Santhanaraj; Anthony Price; Karen W Eldin; Keyur P Patel; Ellen Baker; Kathleen M Schmeler; Rebecca Richards-Kortum
Journal:  PLoS One       Date:  2022-02-25       Impact factor: 3.240

4.  Evaluation and Clinical Validation of Guanidine-Based Inactivation Transport Medium for Preservation of SARS-CoV-2.

Authors:  Hesti L Wiraswati; Shabarni Gaffar; Savira Ekawardhani; Nisa Fauziah; Fedri R Rinawan; Leonardus Widyatmoko; Amila Laelalugina; Annissa R Arimdayu; Tri Kusniati; Clarisa D Andari; Lia Faridah
Journal:  Adv Pharmacol Pharm Sci       Date:  2022-07-21

Review 5.  Determining SARS-CoV-2 non-infectivity state-A brief overview.

Authors:  Siggeir F Brynjolfsson; Hildur Sigurgrimsdottir; Olafur Gudlaugsson; Mar Kristjansson; Karl G Kristinsson; Bjorn R Ludviksson
Journal:  Front Public Health       Date:  2022-08-12

Review 6.  SARS-CoV-2 pandemic: a review of molecular diagnostic tools including sample collection and commercial response with associated advantages and limitations.

Authors:  Harikrishnan Jayamohan; Christopher J Lambert; Himanshu J Sant; Alexander Jafek; Dhruv Patel; Haidong Feng; Michael Beeman; Tawsif Mahmood; Ugochukwu Nze; Bruce K Gale
Journal:  Anal Bioanal Chem       Date:  2020-10-18       Impact factor: 4.142

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.